Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - US
The Guardian - US
World
Marina Dunbar

RARE PHOTOS: Us approves new oral weight loss pill developed by eli lilly | Vintage Vibes

A composite image shows a logo for Eli Lilly on the left and a pill on the right.
Eli Lilly’s GLP-1 drug Foundayo is the latest one in pill form to hit the market. Composite: Reuters, Eli Lilly via AP

The US Food and Drug Administration (FDA) gave the green light on Wednesday to a new oral weight-loss medication developed by the Indianapolis-based pharmaceutical company Eli Lilly.

Known as orforglipron or brand name Foundayo, the once-daily tablet becomes the second GLP-1 drug in pill form to hit the market in a short span of time, arriving after Novo Nordisk’s Wegovy pill received approval in December.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.